Tata Memorial Hospital clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 0 with minor changes only.

1. Notable

   TNBC · Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel…TNBC · Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin · Large Operable or Locally Advanced, Triple Negative Breast Cancer

   Primary and study completion pushed from Nov 30, 2025 to Nov 30, 2026

   Tata Memorial Hospital·Phase 3· NCT03168880· Registry history of NCT03168880 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

2. Notable

   Check Safety of Ayurvedic Oral Cannabis in Breast and Head and…Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

   Primary and study completion pushed from Jun 30, 2025 to Dec 30, 2026

   Tata Memorial Hospital·Phase 1· NCT05969314· Registry history of NCT05969314 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

3. Notable

   Role of Exercise in Women Undergoing Treatment for Breast Cancer

   Primary completion pushed from Mar 31, 2025 to Mar 31, 2027

   Also in this update: Study completion pushed from Apr 30, 2025 to Mar 31, 2027

   Tata Memorial Hospital·Not applicable· NCT02161900· Registry history of NCT02161900 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

4. Notable

   Hypoxia · Peri-operative Hypoxia in Breast Cancer

   Primary completion pushed from Sep 30, 2025 to Dec 30, 2026

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Nov 30, 2025 to Dec 30, 2026

   Tata Memorial Hospital·Not specified· NCT03797482· Registry history of NCT03797482 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.